Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Salem › NPI 1639131535
Hospital

Salem Community Hospital

Salem Community Hospital was paid $11.69M by Medicaid between Jan 2018 and Dec 2024, across 221 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.

33Billing provider infoSALEM COMMUNITY HOSPITAL
SALEM, OH 44460
33aNPI1639131535assigned 04/05/2006
28Total paid$11.69M
24GClaims341,312
24DCodes billed221
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#70 of 101
Median peer was paid$22.32M
This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201832,618$916K
201934,803$970K
202029,802$1.11M
202135,744$1.33M
202239,220$1.52M
202396,360$3.41M
2024incomplete72,765$2.43M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 19,218 17,034 $2.40M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 15,622 14,615 $1.82M
96361 Intravenous infusion, hydration; each additional hour 15% 5,762 4,526 $1.75M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5.1% 9,272 8,191 $594K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 3,656 3,405 $379K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.1% 2,892 1,973 $360K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.9% 1,141 955 $334K
70450 Computed tomography, head or brain; without contrast material 2.4% 1,304 1,102 $282K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.1% 2,252 1,096 $246K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.9% 3,063 2,816 $222K
80053 Comprehensive metabolic panel 1.8% 26,350 21,330 $212K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.7% 1,655 1,420 $196K
209 more codes
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 838 $195K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.6% 1,169 $185K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 831 $173K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.4% 455 $164K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 2,291 $159K
95886 1.4% 706 $159K
87081 <1% 4,830 $115K
71275 Computed tomographic angiography, chest, with contrast material <1% 276 $86K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 899 $77K
96367 <1% 740 $75K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,159 $58K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 31,763 $58K
74018 <1% 1,006 $54K
76830 Ultrasound, transvaginal <1% 395 $52K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,584 $52K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 190 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 478 $46K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 205 $46K
G0378 Hospital observation service, per hour <1% 548 $40K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 61 $38K
84443 Thyroid stimulating hormone (TSH) <1% 3,100 $38K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 216 $37K
71046 Radiologic examination, chest; 2 views <1% 2,047 $37K
77063 Screening digital breast tomosynthesis, bilateral <1% 821 $35K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,783 $34K
80061 Lipid panel <1% 2,503 $31K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 325 $29K
H2020 Therapeutic behavioral services, per diem <1% 245 $28K
82607 <1% 1,869 $25K
36415 Collection of venous blood by venipuncture <1% 39,078 $25K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 85 $23K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,362 $23K
80048 Basic metabolic panel (calcium, ionized) <1% 2,965 $23K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 982 $22K
82728 <1% 2,586 $22K
70551 Magnetic resonance imaging, brain; without contrast material <1% 125 $21K
J1756 Injection, iron sucrose, 1 mg <1% 622 $19K
78815 Positron emission tomography (PET) for limited area imaging <1% 20 $19K
97597 <1% 331 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,037 $17K
83036 Hemoglobin; glycosylated (A1C) <1% 1,512 $17K
81003 <1% 13,120 $17K
84439 <1% 676 $15K
71045 Radiologic examination, chest; single view <1% 4,994 $15K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 58 $15K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 865 $14K
83540 <1% 2,576 $13K
97116 <1% 709 $13K
97161 <1% 265 $12K
71250 <1% 130 $11K
84484 <1% 4,649 $11K
97162 <1% 118 $11K
97165 <1% 171 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,497 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 49 $9K
86140 <1% 649 $9K
73630 <1% 444 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,018 $9K
77067 Screening mammography, bilateral, including computer-aided detection <1% 822 $9K
36591 <1% 2,149 $8K
85027 <1% 994 $8K
72125 Computed tomography, cervical spine; without contrast material <1% 313 $8K
84466 <1% 2,040 $8K
86038 <1% 332 $8K
76641 <1% 48 $8K
84153 <1% 478 $8K
74178 <1% 43 $7K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 14 $7K
71271 <1% 44 $7K
73030 <1% 365 $7K
84145 <1% 1,246 $7K
83735 <1% 3,318 $7K
73130 <1% 310 $6K
73610 <1% 429 $6K
73564 <1% 312 $6K
93971 <1% 66 $6K
59025 Fetal non-stress test <1% 92 $6K
82746 <1% 834 $5K
Q3014 Telehealth originating site facility fee <1% 378 $5K
83550 <1% 484 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 222 $4K
73110 <1% 278 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,204 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 209 $3K
83615 <1% 1,823 $3K
83605 <1% 1,066 $3K
82570 <1% 349 $3K
72110 <1% 95 $3K
85610 <1% 1,252 $3K
87186 <1% 739 $3K
85651 <1% 628 $3K
84703 <1% 4,133 $3K
82140 <1% 335 $3K
82784 <1% 409 $3K
80076 <1% 201 $3K
87088 <1% 628 $3K
76391 <1% 15 $3K
86850 <1% 192 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 5,499 $3K
73502 <1% 176 $3K
82962 <1% 1,666 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,862 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $2K
95819 <1% 18 $2K
72100 <1% 59 $2K
82378 <1% 614 $2K
83880 <1% 748 $2K
86900 <1% 277 $2K
88142 <1% 154 $2K
87510 <1% 89 $2K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 23 $2K
82043 <1% 325 $2K
95912 <1% 246 $2K
H2012 Behavioral health day treatment, per hour <1% 50 $2K
84550 <1% 298 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 514 $2K
96417 <1% 63 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 27 $2K
83690 <1% 1,758 $2K
87480 <1% 89 $2K
76536 <1% 14 $1K
87040 <1% 582 $1K
99213 Doctor's office visit, returning patient (routine) <1% 15 $1K
82077 <1% 516 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 13 $1K
82565 <1% 210 $1K
82553 <1% 411 $1K
96376 <1% 668 $1K
87660 <1% 89 $1K
94060 <1% 13 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 59 $1K
85379 <1% 590 $990.03
87070 <1% 163 $901.20
82248 <1% 81 $806.65
J3010 Injection, fentanyl citrate, 0.1 mg <1% 646 $786.25
85730 <1% 555 $747.65
86901 <1% 277 $724.52
84100 <1% 174 $693.42
82550 <1% 509 $585.39
86706 <1% 28 $557.98
94727 <1% 12 $522.42
87205 <1% 160 $466.48
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,874 $459.34
83921 <1% 132 $421.28
86431 <1% 27 $410.50
J7030 Infusion, normal saline solution , 1000 cc <1% 6,622 $409.47
80143 <1% 155 $407.01
00731 <1% 124 $356.64
73080 <1% 18 $333.93
86592 <1% 30 $321.54
86364 <1% 17 $305.73
84436 <1% 41 $287.80
84403 <1% 24 $281.66
86003 <1% 21 $272.47
94729 <1% 12 $261.18
87077 <1% 22 $254.52
86231 <1% 15 $254.22
82525 <1% 13 $234.98
82785 <1% 15 $219.61
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 17 $210.08
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,069 $207.11
82105 <1% 14 $198.59
85014 <1% 40 $197.11
J1650 Injection, enoxaparin sodium, 10 mg <1% 217 $188.79
88312 <1% 367 $186.41
80074 <1% 14 $177.39
80179 <1% 134 $177.10
J2704 Injection, propofol, 10 mg <1% 1,973 $157.47
82803 <1% 331 $153.39
85045 <1% 153 $152.93
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 30 $125.00
90473 <1% 48 $116.67
85018 <1% 42 $115.63
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,023 $92.28
84702 <1% 15 $89.44
88313 <1% 488 $89.23
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 301 $88.10
84479 <1% 27 $80.04
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 119 $79.59
84156 <1% 20 $74.65
84165 <1% 33 $70.89
84155 <1% 35 $64.39
A9270 Non-covered item or service <1% 2,862 $62.95
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 557 $57.45
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,948 $56.67
84520 <1% 14 $37.32
J2270 Injection, morphine sulfate, up to 10 mg <1% 333 $31.67
J7050 Infusion, normal saline solution, 250 cc <1% 1,173 $31.30
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 186 $28.81
86334 <1% 14 $28.40
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,173 $19.38
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 446 $16.50
J0690 Injection, cefazolin sodium, 500 mg <1% 398 $12.97
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 175 $12.09
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 31 $10.49
87075 <1% 27 $10.09
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 948 $5.11
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 289 $4.32
J2550 Injection, promethazine hcl, up to 50 mg <1% 60 $3.27
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 95 $2.52
00811 0% 103 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 21 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 15 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 13 $0.00
00813 0% 174 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 45 $0.00
J2060 Injection, lorazepam, 2 mg 0% 39 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 31 $0.00
00126 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHACKSTEDDE, ANITA (PRESIDENT/CEO)
Same official

Other billing entities under HACKSTEDDE, ANITA

Full network →
ProviderLocationPaid
Salem Community HospitalSalem, OH$1.04M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.